Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis

Published:2003-06 Issue:6 Volume:126 Page:1419-1429
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Stürzebecher S.,Wandinger K. P.,Rosenwald A.,Sathyamoorthy M.,Tzou A.,Mattar P.,Frank J. A.,Staudt L.,Martin R.,McFarland H. F.

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/126/6/1419/9172126/awg147.pdf

Reference33 articles.

1. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B‐cell lymphoma identified by gene expression profiling. Nature2000; 403: 503–11.

2. Arnason BG. Interferon beta in multiple sclerosis. Clin Immunol Immunopathol1996; 81: 1–11.

3. Becker KG, Simon RM, Bailey‐Wilson JE, et al. Clustering of non‐major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA1998; 95: 9979–84.

4. Bielekova B, Martin R. Multiple sclerosis: immunotherapy. Curr Treat Options Neurol1999; 1: 201–20.

5. Calabresi PA, Tranquill LR, Dambrosia JM, et al. Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta‐1b. Ann Neurol1997; 41: 669–74.

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic Biomarkers of Protein Therapeutics;Protein-based Therapeutics;2023

2. The science and medicine of human immunology;Science;2020-09-25

3. RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation;International Immunopharmacology;2020-06

4. Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy;Scientific Reports;2020-02-13

5. A roadmap to precision medicine for multiple sclerosis;Multiple Sclerosis Journal;2020-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3